COVID Early Home Treatment: Paxlovid becomes 1st US-authorized home COVID treatment
U.S. health regulators authorized the first oral pill against COVID-19 in December 2021 ( Associated Press ), a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. Authorization was based on results from EPIC-HR, a randomized, placebo-controlled treatment trial in adult outpatients with mild-to-moderate COVID who were at high risk for progression to severe disease. What's New: Paxlovid vs Monoclonal Antibodies: What's the Difference ? The latest ( last updated: April 8, 2022 ) NIH guidelines recommended Paxlovid as the no. 1 preferred therapy for non-hospitalized patients. The drug, Paxlovid (ritonavir-boosted nirmatrelvir), is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously authorised drugs against the disease require an IV (intravenous) or an injection. Locations in the USA that may have Paxlovid available can be found at: https://covid-19-ther...